Efficacy of Ganaton (itopride hydrochloride) use in the treatment of patients with functional dyspepsia


Cite item

Full Text

Abstract

We presents the results of study on the efficacy and safety of tricomponent therapy with omeprazole, amoxicillin and nifuratel use based on the results of HP-antigen identification in coprofiltrates, which included 32 children and 35 adults with chronic inflammatory diseases of the upper gastrointestinal tract, associated with Helicobacter pylori (HP). Therapy-induced clinical symptoms improvement and erosive and ulcerative mucosal defects epithelization were noted in all patients. Eradication was achieved in 93.8% of children and 88.6% of adults based on the results of histological examination of biopsy samples and immunochromatographic analysis of fecal specimen. Treatment regimen was well torelated, side effects such as nausea and unformed stool was registered only in 6.3% of children and 8.6% of adults. Thus, the nifuratel-based scheme in combination with omeprazole and amoxicillin is effective and safe for the eradication of HP infection in children and adults. Noninvasive immunochromatographic short-term test based on monoclonal antibodies for the HP-antigens identification in fecal specimen can be used for the diagnosis of HP infection and assessment the efficacy of the therapy.

References

  1. Dunn BE, Cohen Y, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-41.
  2. EUROGAST Study Group. An international association between Helicobacter infection and gastric cancer. Lancet 1993;341:1359-62.
  3. Аруин Л.И., Григорьев П.Я., Исаков В.А. и др. Хронический гастрит. Амстердам, 1993. 370 с.
  4. Логинов А.С., Аруин Л.И., Ильченко А.А. Язвенная болезнь и Helicobacter pylori: новые аспекты патогенетической терапии. М., 1993. 230 с.
  5. Koudryavtseva L, Isakov VA, Ivanikov IO, et al. Evolution of H. pylori primary resistance to antimicrobial agents in Moscow (Russia) in 1996-1998. Gut 2000;47(Suppl. 1):A8.
  6. Циммерман Я.С., Зиннатуллин М.Р. Клиническая медицина. 1999. № 2. С. 52-56.
  7. Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998;115:1272-77.
  8. Hooton C, Dempsey C, Keohane J, et al. Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates. Br J Biomed Sci 2006;63:113-16.
  9. Нижевич А.А., Казанов Р.С., Сатаев В.У. Использование ранитидина, а также амоксициллина и фуразолидона для эрадикации Helicobacter pylori у детей. Gut 2001;49(Suppl. 11):A77.
  10. Щербаков П.Л., Вартапетова Е.Е., Нижевич А.А. и др. Эффективность и безопасность применения висмута трикалия дицитрата (Де-Нол) у детей // Клиническая фармакология и терапия. 2005. Т. 14. № 1. С. 41-44.
  11. Нижевич А.А., Щербаков П.Л., Казанов Р.Ш. и др. Эрадикация Helicobacter pylori у детей после неудачной попытки первичной терапии: преимущества четырехкомпонентной схемы лечения с использованием нифурателя и фуразолидона. Aliment Pharmacol Ther 2005;22:881-87.
  12. Исаков В.А., Домарева И., Кудрявцева Л.В. и др. Сравнение эффективности фуразолидонсодержащей трехкомпонентной и четырехкомпонентной схем эрадикационной терапии при наличии резистентности Helicobacter pylori к метронидазолу. Aliment Pharmacol Ther 2002;16:1277-82.
  13. Нижевич А.А., Сатаев В.У., Ахмадеева А.Г. и др. Тройная нифурателсодержащая антихеликобактерная терапия 1-й линии у детей. Helicobacter 2007;12:132-35.
  14. Wong WM, Wong BCY, Lu H, et al. One-week omeprasole, furasolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies. Aliment Pharmacol Ther 2002;16:793-98.
  15. Liu W-Z, Xiao S-D, Shi Y, et al. Furasolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:317-22.
  16. Fakheri H, Merat S, Hosseini V, et al. Low-dose furasolidone in triple and quadruple regimens of Helicobacter pylori eradication. Aliment Pharmacol Ther 2004;19:89-93.
  17. Elilsur Y, Ruessmann H, Lawrence Z, et al. Clarithromycin resistance in Helicobacter pylori- infected children - West Virginia experience. Helicobacter 2003;8:459.
  18. Kindermann A, Demmelmair H, Koletzko B, et al. Influence of age on 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr 2000;30:85-91.
  19. Imrie C, Rowland M, Bourke B, et al. Limitations to carbon 13-labeled urea breath testing for Helicobacter pylori in infants. J Pediatr 2001;139:734-37.
  20. Khanna B, Cutler A, Israel NR, et al. Use caution with serologic testing for Helicobacter pylori infection in children. J Infect Dis 1998;178:460-65.
  21. Kindermann A, Konstantopoulos N, Lehn N, et al. Evalution of two commercial enzyme immunoassays, testing immunoglobulin G (IgG) and IgA responses for diagnosis of Helicobacter pylori infection in children. J Clin Microbiol 2001;39:3591-96.
  22. Koletzko S, Feydt-Schmidt A. Infants differ from teenagers: use of non-invasive tests for detection of Helicobacter pylori infection in children. Eur J Gastroenterol Hepatol 2001;13:1047-52.
  23. Кашников В.С., Чуков С.З., Семин С.Г. Неинвазивная диагностика Н. pylori - ассоциированных заболеваний в педиатрической практике. Материалы ХII Конгресса детских гастроэнтерологов России. М., 2005. С. 261-262.
  24. Trevisani L, Sartori S, Galvani F, et al. Evalution of a new enzyme immunoassay for detecting Helicobacter pylori in feces: a prospective pilot study. Am J Gastroenterol 1999;94:1830-33.
  25. Vaira D, Malfertheiner P, Megraud F, et al. Diagnosis of Helicobacter pylori with a new non-invasive antigen-based assay. Lancet 1999;354:30-33.
  26. Braden B, Posselt P, Ahrens P, et al. New immunoassay in stool provides an accurate noninvasive diagnostic method for Helicobacter pylori screening in children. Pediatrics 2000;106:115-17.
  27. Oderda G, Rappa A, Ronchi B, et al. Detection of Helicobacter pylori in stool specimens by noninvasive antigen enzyme immunoassay in children: multicentre Italian study. BMJ 2000;320:347-48.
  28. Konstantopoulos N, Russmann H, Tasch C, et al. Evalution of the Helicobacter pylori stool antigen test (HpSA) for detection of Helicobacter pylori infection in children. Am J Gastroenterolog 2001;96:677-83.
  29. Oderda G, Rappa A, Marinello D, et al. Usefulness of Helicobacter pylori stool antigen test to monitor response to eradication treatment in children. Aliment Pharmacol Ther 2001;15:203-06.
  30. Megraud F. Non-invasive tests to detect Helicobacter pylori infection in children and adolescents: results of multicentric European study. J Pediatr 2005;146:198-203.
  31. Koletzko S, Konstantopoulos N, Bosman D, et al. Evalution of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from children. Gut 2003;52:804-06.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies